Senate BillPassed first house
S 8925: Prohibits the sale of products that contain 7-hydroxymitragynine at a level that exceeds 2% of total alkaloids or one milligram per serving; establishes fines for the sale of such products.
What S 8925 does, verified June 9, 2026
The proposed law aims to prohibit the sale of certain products that contain 7-hydroxymitragynine, a synthetic opioid. It defines 7-hydroxymitragynine products as substances that exceed two percent of total alkaloids or contain one milligram per serving. The law applies to the sale, offer for sale, delivery, or distribution of these products. Business entities found guilty of knowingly selling, offering for sale, or delivering 7-hydroxymitragynine products may face a civil penalty of up to three thousand dollars for the first violation and sixty-five hundred dollars for each subsequent violation. The collected fines will be deposited into the New York State Drug Treatment and Public Education Fund. The law will take effect ninety days after it becomes a law.
Bill journey
✓IntroducedComplete
✓In CommitteeComplete
✓First Chamber FloorComplete
4Second ChamberCurrent
5GovernorPending
6ChapteredPending
Last action: returned to senate (2026-06-05)Alert me
Quick answers about S 8925
- What is the current status of S 8925?
- As of June 9, 2026, S 8925 is recorded as "Passed first house": it has passed the chamber it started in and is now before the second chamber. The last recorded action, on June 5, 2026, was "returned to senate".
- Did S 8925 pass?
- Not yet. S 8925 has passed its house of origin and is now before the second chamber, where it needs committee approval and a floor vote.
- Who wrote S 8925, and where is it now?
- S 8925 was authored by Sen. Chris Ryan with 6 coauthors.
Author and sponsors
Full contact details, staff, and committees with Connect, $16/moUnlockRecent actions13 total · showing 5
| Jun. 05, 2026 | returned to senate |
| Jun. 05, 2026 | passed assembly |
| Jun. 03, 2026 | ordered to third reading rules cal.408 |
| Jun. 03, 2026 | substituted for a9156b |
| Jun. 02, 2026 | referred to ways and means |
Latest bill textIntroduced version, January 16, 2026 · 370 words
STATE OF NEW YORK ________________________________________________________________________ 8925 IN SENATE January 16, 2026 ___________ Introduced by Sen. C. RYAN -- read twice and ordered printed, and when printed to be committed to the Committee on Consumer Protection AN ACT to amend the general business law, in relation to prohibiting the sale of 7-hydroxymitragynine products The People of the State of New York, represented in Senate and Assem- bly, do enact as follows: 1 Section 1. The general business law is amended by adding a new section 2 392-l to read as follows: 3 § 392-l. Sale of 7-hydroxymitragynine products. 1. For purposes of 4 this section, the term "7-hydroxymitragynine products" shall mean any 5 substance, material, mixture, compound, preparation, extract, or 6 finished goods that contains 7-hydroxymitragynine at a level that 7 exceeds two percent of total alkaloids or one milligram per serving. 8 2. The provisions of this section shall apply to the sale, offer for 9 sale, delivery, or distribution of all 7-hydroxymitragynine products. 10 3. No corporation, partnership, limited liability company, firm, 11 online platform, or any other business entity doing business within this 12 state shall knowingly sell, offer for sale, or deliver 7-hydroxymitragy- 13 nine products. 14 4. Any corporation, partnership, limited liability company, firm, 15 online platform, or other business entity doing business within this 16 state that violates the provisions of this section by knowingly selling, 17 offering for sale, or delivering 7-hydroxymitragynine products shall be 18 subject to a civil penalty of not more than three thousand dollars for a 19 first violation, and sixty-five hundred dollars for each subsequent 20 violation, recoverable in an action by the attorney general of the state 21 of New York. All funds collected or received by the state from civil 22 penalties imposed under this section shall be deposited in the New York 23 state drug treatment and public education fund established pursuant to 24 section ninety-nine-jj of the state finance law. 25 § 2. This act shall take effect on the ninetieth day after it shall 26 have become a law. EXPLANATION--Matter in italics (underscored) is new; matter in brackets [] is old law to be omitted. LBD13840-03-6
Text of S 8925 as introduced, from the official record. Connect Plus keeps every version and highlights what changed.Compare versions